UOC
SILK

UBS O'Connor’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

UBS O'Connor’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-90,556
Closed -$1.66M – 649
2024
Q1 		$1.66M Buy
90,556
+18,000
+25% +$286K 0.05% 215
2023
Q4 		$890K Buy
72,556
+26,028
+56% +$244K 0.03% 284
2023
Q3 		$697K Sell
46,528
-10,000
-18% -$208K 0.01% 366
2023
Q2 		$1.84M Buy
56,528
+17,046
+43% +$622K 0.04% 314
2023
Q1 		$1.54M Buy
+39,482
New +$1.93M 0.04% 365
2022
Q4 		– Sell
-33,230
Closed -$1.5M – 436
2022
Q3 		$1.5M Sell
33,230
-28,500
-46% -$1.23M 0.02% 690
2022
Q2 		$2.25M Buy
+61,730
New +$2.24M 0.02% 624
2020
Q3 		– Sell
-43,828
Closed -$1.84M – 416
2020
Q2 		$1.84M Buy
43,828
+24,488
+127% +$940K 0.04% 234
2020
Q1 		$609K Sell
19,340
-24,960
-56% -$999K 0.01% 257
2019
Q4 		$1.79M Buy
44,300
+5,250
+13% +$184K 0.05% 199
2019
Q3 		$1.27M Buy
+39,050
New +$1.56M 0.04% 197

Other funds holding SILK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

UBS O'Connor's SILK Position: Q2 2024 in Review

UBS O'Connor sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 90,556 shares — an estimated $1.66M sold.

UBS O'Connor first reported a position in SILK in Q3 2019 and held it in 11 quarters. The position peaked at $2.25M in Q2 2022. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • UBS O'Connor reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 90,556 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.66M.
  • UBS O'Connor first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • UBS O'Connor's Silk Road Medical, Inc. Common Stock position peaked at $2.25M in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.